Results 41 to 50 of about 347,907 (259)

Active surveillance of low-risk papillary thyroid microcarcinoma.

open access: yesBest practice & research. Clinical endocrinology & metabolism, 2022
Recently, the incidence of thyroid carcinoma has been increasing rapidly worldwide. This is interpreted as an increase in the incidental detection of small papillary thyroid carcinomas by the widespread use of high-resolution imaging techniques such as ...
I. Sugitani
semanticscholar   +1 more source

Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance [PDF]

open access: yes, 2020
Background: Papillary thyroid microcarcinoma is a subtype of thyroid cancer that may be managed with active surveillance rather than immediate surgery. Active surveillance decreases complication rates and may decrease health care costs.
Sidhu, Stanley B.   +19 more
core   +1 more source

A Case of Thyroid Hemiagenesis: An Exceptional Case

open access: yesEndocrinology Research and Practice, 2018
Thyroid hemiagenesis is a rare congenital anomaly in which one thyroid lobe fails to develop. We recently observed a case of thyroid hemiagenesis accompanied by parathyroid adenoma and papillary thyroid microcarcinoma in a 51-years-old woman. The patient’
Banu Pinar ŞARER YÜREKLİ   +5 more
doaj   +1 more source

Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up

open access: yesThyroid
Background: The longest reported follow-up for thermal ablation of papillary thyroid microcarcinoma (PTMC) is 5 years. We evaluated the long-term efficacy and safety of radiofrequency ablation (RFA) in patients with low-risk PTMC with clinical follow-up ...
So Yeong Jeong   +5 more
semanticscholar   +1 more source

A multicenter cohort study of thyroidectomy-related decision regret in patients with low-risk papillary thyroid microcarcinoma

open access: yesNature Communications
The level of thyroidectomy-related regret in patients with clinically low-risk papillary thyroid microcarcinoma (PTMC) and the determinants of decision regret are largely unknown. Here, we show that 319 (24.2%) of those who undergo thyroidectomy and 4 (3.
Gen-Peng Li   +10 more
semanticscholar   +1 more source

Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis

open access: yesWorld Journal of Surgical Oncology, 2022
Background The presence of central lymph node metastases (CLNM) has been suggested as a risk factor for poorer prognosis and recurrence in papillary thyroid microcarcinoma (PTMC). However, the clinicopathologic factors for CLNM in clinical node-negative (
X. Wen   +4 more
semanticscholar   +1 more source

PROS1‐MERTK Axis Drives Tumor Microenvironment Crosstalk and Progression in Papillary Thyroid Microcarcinoma

open access: yesAdvancement of science
The incidence of papillary thyroid carcinoma (PTC) has been rising annually, with papillary thyroid microcarcinoma (PTMC) accounting for more than half of the cases.
Wen-Qian Zhang   +11 more
semanticscholar   +1 more source

Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients

open access: yesWorld Journal of Surgical Oncology, 2022
Background Extrathyroidal extension (ETE) is considered a major prognostic factor in papillary thyroid carcinoma (PTC). Patients with gross ETE are at increased risk of recurrence and mortality.
R. Song, H. Kim, K. Kang
semanticscholar   +1 more source

Papillary thyroid microcarcinoma: a painstaking category to manage

open access: yes, 2014
Papillary thyroid microcarcinoma: a painstaking category to ...
Maurizio Martini   +7 more
core   +1 more source

Incidental thyroid papillary microcarcinoma: survival and follow‐up [PDF]

open access: yes, 2019
Objectives/Hypothesis : The aim was to study the survival of incidental thyroid papillary microcarcinoma patients treated with surgery for benign thyroid disease to validate absence of oncological follow‐up and reduce unnecessary health expenses.
Agnès Dupret‐Bories   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy